Can-Fite BioPharma CANF Cash Flow Statement (2013-2023)

NYSE CANF
$2.21 +0.03 (+1.61%)
As of: Sep 30, 2026 · 3:58 PM EDT
Reported Financials

Can-Fite BioPharma Quarterly Cash Flow Statement

Periods 39 quarters
Latest Dec 2023

Can-Fite BioPharma cash flow statement data for the quarter ended Dec 2023. This cash flow statement covers 39 quarters of results from Sep 2013 through Dec 2023, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2013 Mar2014 Jun2014 Sep2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023
Operating Activities
Net Income
-3.43M1.83M-6.72M-2.95M-4.78M-3.89M-2.58M-3.63M-1.88M-3.22M-3.40M-4.12M-2.43M-2.19M-2.53M-0.48M-2.71M-1.78M-1.76M-1.65M
Share-based CompensationStock Comp.
Cash from OperationsCash from Ops.
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
Change in Working Capital
Change in ReceivablesChange Receivables
Change in Account PayablesChange Payables
Additional items
Exchange Rate EffectFX Effect
Free Cash FlowFCF
Net Cash FlowNCF

Can-Fite BioPharma Cash Flow Statement API

Pull Can-Fite BioPharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CANF&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY